Breast Cancer Biomarkers: Challenges in Routine Estrogen Receptor, Progesterone Receptor, and HER2/neu Evaluation.
Context.--Evaluation of estrogen receptor (ER), progesterone receptor (PR), and HER2/neu (HER2) biomarkers is standard of care for all cases of newly diagnosed invasive, recurrent, and metastatic breast cancer. Repeat analysis is also performed in select cases per College of American Pathologists/Am...
| Published in: | Archives of Pathology & Laboratory Medicine Vol. 143; no. 12; pp. 1444 - 1450 |
|---|---|
| Main Author: | |
| Format: | pictorial review Journal Article |
| Published: |
College of American Pathologists
Dec2019
|
| Online Access: | View this record in EBSCOhost |